Overview—Flavonoids: A New Family of Benzodiazepine Receptor Ligands

Benzodiazepines (BDZs) are the most widely prescribed class of psychoactive drugs in current therapeutic use, despite the important unwanted side-effects that they produce such as sedation, myorelaxation, ataxia, amnesia, ethanol and barbiturate potentiation and tolerance. Searching for safer BDZ-receptor (BDZ-R) ligands we have recently demonstrated the existence of a new family of ligands which have a flavonoid structure. First isolated from plants used as tranquilizers in folkloric medicine, some natural flavonoids have shown to possess a selective and relatively mild affinity for BDZ-Rs and a pharmacological profile compatible with a partial agonistic action. In a logical extension of this discovery various synthetic derivatives of those compounds, such as 6,3′-dinitroflavone were found to have a very potent anxiolytic effect not associated with myorelaxant, amnestic or sedative actions. This dinitro compound, in particular, exhibits a high affinity for the BDZ-Rs (Ki = 12–30 nM). Due to their selective pharmacological profile and low intrinsic efficacy at the BDZ-Rs, flavonoid derivatives, such as those described, could represent an improved therapeutic tool in the treatment of anxiety. In addition, several flavone derivatives may provide important leads for the development of potent and selective BDZ-Rs ligands.

[1]  S. Frokjaer,et al.  High affinity of the naturally-occurring biflavonoid, amentoflavon, to brain benzodiazepine receptors in vitro. , 1988, Biochemical pharmacology.

[2]  M. Feely,et al.  RO 16-6028, a benzodiazepine receptor partial agonist, does not exhibit anticonvulsant tolerance in mice. , 1988, European journal of pharmacology.

[3]  M. Ruckstuhl,et al.  Flavonoids are selective cyclic GMP phosphodiesterase inhibitors. , 1979, Biochemical pharmacology.

[4]  G. Perrault,et al.  Repeated treatment with alpidem, a new anxiolytic, does not induce tolerance or physical dependence , 1993, Neuropharmacology.

[5]  D. Greenblatt,et al.  Chronic benzodiazepine administration. IV. Rapid development of tolerance and receptor downregulation associated with alprazolam administration. , 1989, Biochemical pharmacology.

[6]  D J Greenblatt,et al.  Interaction of caffeine with the GABAA receptor complex: alterations in receptor function but not ligand binding. , 1989, European journal of pharmacology.

[7]  B. Scatton,et al.  Autoradiographic Localization of [3H]Zolpidem Binding Sites in the Rat CNS: Comparison with the Distribution of [3H]Flunitrazepam Binding Sites , 1987, Journal of neurochemistry.

[8]  D. Greenblatt,et al.  Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation. , 1990, Archives of general psychiatry.

[9]  I. Izquierdo,et al.  Benzodiazepine receptor ligand influences on acquisition: suggestion of an endogenous modulatory mechanism mediated by benzodiazepine receptors. , 1990, Behavioral and neural biology.

[10]  R. Lister.  The amnesic action of benzodiazepines in man , 1985, Neuroscience & Biobehavioral Reviews.

[11]  V. Cody,et al.  Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. , 1989, Biochemical pharmacology.

[12]  K. H. Kimbel,et al.  Ginkgo biloba , 1992, The Lancet.

[13]  D. Pilbeam.  The Flavonoids: Advances in Research : Edited by J.B. Harborne and T.J. Mabry Chapman and Hall; London, New York, 1982 744 pages. £ 49.50 , 1983 .

[14]  A. Guidotti,et al.  Benzodiazepines on trial: a research strategy for their rehabilitation. , 1996, Trends in pharmacological sciences.

[15]  H. Mohler,et al.  Benzodiazepine receptor: demonstration in the central nervous system , 1977, Science.

[16]  P. Fuchs,et al.  Myricetin and quercetin, the flavonoid constituents ofGinkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca2+-loaded brain neurons , 1994, Brain Research.

[17]  J H Medina,et al.  Chrysin (5,7-di-OH-flavone), a naturally-occurring ligand for benzodiazepine receptors, with anticonvulsant properties. , 1990, Biochemical pharmacology.

[18]  I. Izquierdo,et al.  Inhibitory Avoidance Training Induces Rapid and Selective Changes in3[H]AMPA Receptor Binding in the Rat Hippocampal Formation , 1995, Neurobiology of Learning and Memory.

[19]  S. Cheav,et al.  Effect of two flavonoid compounds on central nervous system. Analgesic activity. , 1991, Life sciences.

[20]  W. Haefely,et al.  Aspects of benzodiazepine receptor structure and function with relevance to drug tolerance and dependence. , 1993, Biochemical Society symposium.

[21]  D. Smee,et al.  Antiherpesvirus activity and mode of action of SP-303, a novel plant flavonoid. , 1993, Chemotherapy.

[22]  W. Haefely,et al.  Novel anxiolytics that act as partial agonists at benzodiazepine receptors. , 1990, Trends in pharmacological sciences.

[23]  C. Braestrup,et al.  Benzodiazepine receptors in rat brain , 1977, Nature.

[24]  L. Sternbach.  The benzodiazepine story. , 1983, Journal of psychoactive drugs.

[25]  H. Viola,et al.  6-Bromoflavone, a high affinity ligand for the central benzodiazepine receptors is a member of a family of active flavonoids. , 1996, Biochemical and biophysical research communications.

[26]  O. Sterner,et al.  Inhibition of [methyl-3H]diazepam binding to rat brain membranes in vitro by dinatin and skrofulein. , 1994, Zhongguo yao li xue bao = Acta pharmacologica Sinica.

[27]  J. Medina,et al.  Cirsiliol and caffeic acid ethyl ester, isolated from Salvia guaranitica, are competitive ligands for the central benzodiazepine receptors. , 1996, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[28]  Jeffrey B. Harborne,et al.  The Flavonoids Advances in Research Since 1986 , 1993 .

[29]  S. Snyder,et al.  Kinetic differences between type I and type II benzodiazepine receptors. , 1984, Molecular pharmacology.

[30]  H. Häberlein,et al.  Flavonoids from Leptospermum scoparium with affinity to the benzodiazepine receptor characterized by structure activity relationships and in vivo studies of a plant extract. , 1994, Die Pharmazie.

[31]  I. Izquierdo,et al.  GABAA receptor modulation of memory: the role of endogenous benzodiazepines. , 1991, Trends in pharmacological sciences.

[32]  J. Phillis,et al.  The role of adenosine in the central actions of the benzodiazepines , 1988, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[33]  J. Medina,et al.  Production of benzodiazepine-like compounds in bovine rumen. , 1991, Biochemical and biophysical research communications.

[34]  R. O'brien,et al.  Isolation and identification of "diazepam-like" compounds from bovine urine. , 1983, Journal of natural products.

[35]  J. Medina,et al.  Isolation of pharmacologically active benzodiazepine receptor ligands from Tilia tomentosa (Tiliaceae). , 1994, Journal of ethnopharmacology.

[36]  J. Medina,et al.  Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora Coerulea , 1994, Pharmacology Biochemistry and Behavior.

[37]  R J Miksicek,et al.  Commonly occurring plant flavonoids have estrogenic activity. , 1993, Molecular pharmacology.

[38]  D. Nutt.  Benzodiazepine dependence in the clinic: reason for anxiety? , 1986 .

[39]  M. Thiébot.  Some evidence for amnesic-like effects of benzodiazepines in animals , 1985, Neuroscience & Biobehavioral Reviews.

[40]  J. Paysan,et al.  Heterogeneity of GABAA-receptors: cell-specific expression, pharmacology, and regulation , 1995, Neurochemical Research.

[41]  R. Geahlen,et al.  Synthesis and protein-tyrosine kinase inhibitory activities of flavonoid analogues. , 1991, Journal of medicinal chemistry.

[42]  W. Jäger,et al.  In vitro inhibition of adenosine deaminase by flavonoids and related compounds. New insight into the mechanism of action of plant phenolics. , 1992, Methods and findings in experimental and clinical pharmacology.

[43]  L. Pieri,et al.  Physical dependence induced in DBA/2J mice by benzodiazepine receptor full agonists, but not by the partial agonist Ro 16-6028. , 1990, European journal of pharmacology.

[44]  J. Woods,et al.  Benzodiazepines: use, abuse, and consequences. , 1992, Pharmacological reviews.

[45]  Gallager Dw,et al.  Benzodiazepine tolerance and dependence: GABAA receptor complex locus of change. , 1993 .

[46]  K. Jacobson,et al.  Interactions of flavonoids and other phytochemicals with adenosine receptors. , 1996, Journal of Medicinal Chemistry.

[47]  L. Tye,et al.  Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. , 1990, Cancer research.

[48]  W. Sieghart,et al.  Molecular heterogeneity of benzodiazepine receptors , 1980, Nature.

[49]  E. Bixler,et al.  Alprazolam: Effects on Sleep and Withdrawal Phenomena , 1987, Journal of clinical pharmacology.

[50]  M. Lader,et al.  Studies with alpidem in normal volunteers and anxious patients. , 1990, Pharmacopsychiatry.

[51]  D. Greenblatt,et al.  Chronic benzodiazepine administration , 2005, Psychopharmacology.

[52]  J. Medina,et al.  Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects. , 1995, Planta medica.

[53]  J. Medina,et al.  Benzodiazepine-like molecules, as well as other ligands for the brain benzodiazepine receptors, are relatively common constituents of plants. , 1989, Biochemical and biophysical research communications.

[54]  R. Mckernan,et al.  Which GABAA-receptor subtypes really occur in the brain? , 1996, Trends in Neurosciences.

[55]  J. Venter,et al.  Benzodiazepine/GABA receptors and chloride channels : structural and functional properties , 1986 .